Generally considered as an oncogenic factor, DLGAP1-AS2 has recently been reported to modulate the tumorigenesis and progression of several tumors, such as HCC [24], CCA [25], and Glioma [26]. The gene discussed is DLGAP1; the disease is central nervous system cancer.